These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 24556126)

  • 1. Effectively "cross-bridged" hemostatic and blood screening test defects due to glycogenosis type 1 associated extremely hyperlipidemia.
    Balint B; Todorovic-Balint M; Petakov M; Ostojic G; Vucetic D
    Transfus Apher Sci; 2014 Apr; 50(2):314-5. PubMed ID: 24556126
    [No Abstract]   [Full Text] [Related]  

  • 2. Progression of renal damage in glycogen storage disease type I is associated to hyperlipidemia: a multicenter prospective Italian study.
    Melis D; Cozzolino M; Minopoli G; Balivo F; Parini R; Rigoldi M; Paci S; Dionisi-Vici C; Burlina A; Andria G; Parenti G
    J Pediatr; 2015 Apr; 166(4):1079-82. PubMed ID: 25641239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased lipogenesis and resistance of lipoproteins to oxidative modification in two patients with glycogen storage disease type 1a.
    Bandsma RH; Rake JP; Visser G; Neese RA; Hellerstein MK; van Duyvenvoorde W; Princen HM; Stellaard F; Smit GP; Kuipers F
    J Pediatr; 2002 Feb; 140(2):256-60. PubMed ID: 11865283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menorrhagia in patients with type I glycogen storage disease.
    Austin SL; El-Gharbawy AH; Kasturi VG; James A; Kishnani PS
    Obstet Gynecol; 2013 Dec; 122(6):1246-54. PubMed ID: 24201678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hyperlipidemia in glycogen storage disease.
    Jakovcic S; Khachadurian AK; Hsia DY
    J Lab Clin Med; 1966 Nov; 68(5):769-79. PubMed ID: 5223987
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of malonaldehyde in hyperlipemic sera.
    Keddad K; Conti M; Baussan C; Lemonnier A
    Clin Chem; 1993 Oct; 39(10):2202-3. PubMed ID: 8403410
    [No Abstract]   [Full Text] [Related]  

  • 7. [Metabolic adaptation in the fasting test in children with glycogenosis type I].
    Bührdel P; Hubald J; Böhme HJ
    Kinderarztl Prax; 1987 Nov; 55(11):537-42. PubMed ID: 3326965
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemorrhagic pancreatitis in a patient with glycogen storage disease type I.
    Michels VV; Beaudet AL
    Clin Genet; 1980; 17(3):220-2. PubMed ID: 6928812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Platelet dysfunction in glycogen storage disease type I (GSD-I) (author's transl)].
    Oya N; Sawada T; Kusunoki T; Nishizawa A; Watada M
    Rinsho Ketsueki; 1975 Jul; 16(7):736-42. PubMed ID: 1058319
    [No Abstract]   [Full Text] [Related]  

  • 10. [Gout as a complication of adult glycogen storage disease].
    Neubaur J; Willms B; Söling HD; Creutzfeldt W
    Arch Klin Med; 1969; 216(2):148-60. PubMed ID: 5256428
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical and biochemical aspects of type I glycogenosis].
    Rossi A la R; Nacagami J; Strufaldi B; Nozaki MJ
    Rev Farm Bioquim Univ Sao Paulo; 1973; 11(2):196-208. PubMed ID: 4373797
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of bone changes in glycogenosis. I. Nephrogenic rickets in type I glycogenosis].
    Halikowski B; Kucharska K; Stopyrowa J
    Pediatr Pol; 1970 Mar; 45(3):285-91. PubMed ID: 4315073
    [No Abstract]   [Full Text] [Related]  

  • 13. [Formation of platelet thromboxane in a patient with type I glycogenosis].
    Strano A; Davì G; Averna M; Benigno V; D'Alessandro G; La Grutta A; Notarbartolo A
    Recenti Prog Med; 1985 Dec; 76(12):619-22. PubMed ID: 3868788
    [No Abstract]   [Full Text] [Related]  

  • 14. [Gout in the evolution of Von Gierke's disease].
    Benedetti A; Bucciante G; Cattano G; Nardini A
    Minerva Med; 1969 May; 60(38):1849-59. PubMed ID: 5255205
    [No Abstract]   [Full Text] [Related]  

  • 15. Secondary metabolic changes in von Gierke's disease (Type I glycogen storage disease).
    Blackett PR
    Ann Clin Lab Sci; 1982; 12(5):424-30. PubMed ID: 6753728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Neutropenia and glycogenosis type IB].
    Couselo Sánchez JM; López Rivas M; Pérez Becerra E; Rodríguez Cervilla J; Pavón Belinchón P; Fraga Bermúdez JM; Peña Guitián J
    An Esp Pediatr; 1983 Jun; 18(6):505-9. PubMed ID: 6578695
    [No Abstract]   [Full Text] [Related]  

  • 17. The hemostatic defect in glycogen storage disease, type 1.
    Gilchrist GS; Fine RN; Donnell GN
    Acta Paediatr Scand; 1968 May; 57(3):205-8. PubMed ID: 5249486
    [No Abstract]   [Full Text] [Related]  

  • 18. Short communication. Glycogenosis Ib: neutrophil microbicidal defects due to impaired hexose monophosphate shunt.
    Seger R; Steinmann B; Tiefenauer L; Matsunaga T; Gitzelmann R
    Pediatr Res; 1984 Mar; 18(3):297-9. PubMed ID: 6328404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unusual form of glycogenosis type 1 (Gierke's disease)].
    Chibisov IV; Rozenfel'd EL; Chistova LV; Leont'ev AF; Mantasheva VA
    Vopr Okhr Materin Det; 1978 Mar; 23(3):81-4. PubMed ID: 274013
    [No Abstract]   [Full Text] [Related]  

  • 20. Surgical therapy of glycogen storage disease.
    Boley SJ; Cohen MI; Gliedman ML
    Pediatrics; 1970 Dec; 46(6):929-33. PubMed ID: 5275633
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.